Largest pharmaceutical companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 pharmaceutical companies ranked by total assets, at CA$298.4B, ahead of Johnson & Johnson (CA$285.6B) and Sanofi (CA$201.7B). Figures as of 18 Nov 2026, 16:47 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerCA$298.4B
- Median
- CA$5.1B
- Combined market value
- CA$7.29T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | CA$298.4B | CA$230.3B | CA$40.41 | 1.00% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | CA$285.6B | CA$951.7B | CA$395.35 | 1.05% down | 38% up | ||
| 3 | SanofiSNY · Health Care | CA$201.7B | CA$162.9B | CA$67.83 | 0.45% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | CA$196.2B | CA$493.5B | CA$200.20 | 2.60% down | 51% up | ||
| 5 | AbbVieABBV · Health Care | CA$192.1B | CA$732.7B | CA$414.53 | 1.26% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | CA$163.5B | CA$398.7B | CA$257.06 | 1.63% down | 2% up | ||
| 7 | Eli LillyLLY · Health Care | CA$161.3B | CA$1.77T | CA$1,987.68 | 2.06% down | 35% up | ||
| 8 | NovartisNVS · Health Care | CA$159.1B | CA$422.2B | CA$223.54 | 2.02% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | CA$139.3B | CA$97.9B | CA$30.64 | 1.22% down | 54% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | CA$129.1B | CA$176.4B | CA$86.32 | 1.86% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | CA$124.3B | CA$260.6B | CA$150.45 | 0.22% up | 17% down | ||
| 12 | GSKGSK · Health Care | CA$116.3B | CA$140.2B | CA$69.95 | 0.91% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | CA$115.5B | CA$249.8B | CA$56.69 | 2.85% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | CA$58.4B | CA$70.7B | CA$60.59 | 0.84% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | CA$58.1B | CA$141.8B | CA$1,371.11 | 0.15% down | 36% up | ||
| 16 | ViatrisVTRS · Health Care | CA$53.3B | CA$33.8B | CA$29.48 | 0.56% up | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | CA$36.8B | CA$194.6B | CA$767.41 | 0.20% up | 27% up | ||
| 18 | GrifolsGRFS · Health Care | CA$31.4B | CA$8.3B | CA$12.21 | 1.33% down | 1% up | ||
| 19 | Royalty PharmaRPRX · Health Care | CA$28.1B | CA$56.8B | CA$98.72 | 0.26% up | 78% up | ||
| 20 | ZoetisZTS · Health Care | CA$22.2B | CA$48.9B | CA$120.38 | 0.58% up | 29% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | CA$19.2B | CA$19B | CA$37.94 | 2.36% up | 20% up | ||
| 22 | GenmabGMAB · Health Care | CA$18.5B | CA$45.3B | CA$73.40 | 1.46% down | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | CA$16.7B | CA$22.5B | CA$350.00 | 1.42% up | 37% up | ||
| 24 | BeOne MedicinesONC · Health Care | CA$11.7B | CA$66B | CA$577.86 | 2.47% down | 17% up | ||
| 25 | United TherapeuticsUTHR · Health Care | CA$11.3B | CA$35.3B | CA$829.57 | 0.94% down | 23% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | CA$10.9B | CA$16.7B | CA$86.44 | 3.04% up | 11% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | CA$8.8B | CA$17.9B | CA$21.48 | 1.32% up | 5% up | ||
| 28 | Roivant SciencesROIV · Health Care | CA$8.2B | CA$40B | CA$55.15 | 0.62% down | 90% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | CA$7.1B | CA$29.1B | CA$217.37 | 3.12% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | CA$5.3B | CA$10.8B | CA$30.90 | 2.06% up | 83% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | CA$5.1B | CA$6.5B | CA$39.30 | 1.67% up | 64% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | CA$4.2B | CA$7.2B | CA$86.52 | 0.02% down | 20% down | ||
| 33 | AlkermesALKS · Health Care | CA$3.6B | CA$11.2B | CA$66.91 | 2.68% up | 58% up | ||
| 34 | InsmedINSM · Health Care | CA$3.2B | CA$37.8B | CA$172.46 | 1.28% down | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | CA$2.5B | CA$4.5B | CA$23.27 | 0.74% up | 42% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | CA$2.2B | CA$8.6B | CA$430.32 | 2.16% up | 43% up | ||
| 37 | Ascendis PharmaASND · Health Care | CA$2.1B | CA$25.5B | CA$388.63 | 0.04% down | 28% up | ||
| 38 | CytokineticsCYTK · Health Care | CA$2B | CA$10.2B | CA$73.47 | 0.78% down | 20% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | CA$2B | CA$8.7B | CA$61.68 | 0.07% up | 10% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | CA$1.8B | CA$13.5B | CA$581.31 | 3.91% down | 24% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | CA$1.5B | CA$14.1B | CA$93.59 | 4.10% up | 107% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | CA$1.3B | CA$12.2B | CA$437.83 | 0.11% up | 61% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | CA$1.3B | CA$7B | CA$40.51 | 1.45% up | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | CA$1.3B | CA$21.7B | CA$111.33 | 1.11% up | 17% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | CA$1.2B | CA$8.6B | CA$131.11 | 0.54% down | 31% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | CA$1.2B | CA$10.7B | CA$97.56 | 2.88% down | 8% down | ||
| 47 | Belite BioBLTE · Health Care | CA$1.1B | CA$9.2B | CA$226.71 | 0.26% up | 31% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | CA$1.1B | CA$13B | CA$136.77 | 1.69% up | 286% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CA$1.1B | CA$10.8B | CA$137.61 | 0.92% up | 126% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | CA$1.1B | CA$12.2B | CA$15.21 | 0.56% down | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | CA$989M | CA$10.1B | CA$192.03 | 1.48% down | 7% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | CA$958M | CA$11.7B | CA$179.80 | 0.59% up | 46% up | ||
| 53 | ABIVAXABVX · Health Care | CA$929.5M | CA$10.5B | CA$119.87 | 1.84% up | 27% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | CA$867.7M | CA$6.9B | CA$72.12 | 1.56% down | 44% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | CA$792.3M | CA$6.5B | CA$59.07 | 2.00% down | 88% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | CA$761.2M | CA$7B | CA$124.34 | 0.29% down | 113% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | CA$700.5M | CA$9.4B | CA$138.34 | 0.18% up | 241% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | CA$688.4M | CA$11.6B | CA$167.84 | 0.39% up | 13% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | CA$631M | CA$5.6B | CA$40.97 | 2.72% down | 169% up | ||
| 60 | ErascaERAS · Health Care | CA$568M | CA$6.6B | CA$18.80 | 5.62% down | 403% up | ||
| 61 | VeradermicsMANE · Health Care | CA$218.8M | CA$7.5B | CA$177.87 | 1.25% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.4337 CAD).
Questions and answers
Which pharmaceutical companies rank first by total assets?
Pfizer (CA$298.4B), Johnson & Johnson (CA$285.6B) and Sanofi (CA$201.7B) are the top three of the 61 pharmaceutical companies ranked by total assets as of 18 Nov 2026, 16:47 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by total assets.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by total assets have a combined market value of CA$7.29T as of 18 Nov 2026, 16:47 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.